David S. Rickman

10.9k total citations · 1 hit paper
63 papers, 5.6k citations indexed

About

David S. Rickman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David S. Rickman has authored 63 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 22 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in David S. Rickman's work include Prostate Cancer Treatment and Research (19 papers), Cancer-related gene regulation (9 papers) and Ubiquitin and proteasome pathways (8 papers). David S. Rickman is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Cancer-related gene regulation (9 papers) and Ubiquitin and proteasome pathways (8 papers). David S. Rickman collaborates with scholars based in United States, France and Germany. David S. Rickman's co-authors include Aurélien de Reyniès, Mark A. Rubin, Francesca Demichelis, Himisha Beltran, Sandrine Boyault, Jean Saric, Aurélie Hérault, Sandra Rebouissou, Paulette Bioulac‐Sage and Pierre Laurent‐Puig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

David S. Rickman

63 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

2006 907 citations David S. Rickman, Aurélien de Reyniès et al. Hepatology profile →

Peers

Countries citing papers authored by David S. Rickman

Since Specialization

Citations

This map shows the geographic impact of David S. Rickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Rickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Rickman more than expected).

Fields of papers citing papers by David S. Rickman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Rickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Rickman. The network helps show where David S. Rickman may publish in the future.

Co-authorship network of co-authors of David S. Rickman

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Rickman. A scholar is included among the top collaborators of David S. Rickman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Rickman. David S. Rickman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer 2022 ·eLife ·(unknown), (unknown), (unknown), (unknown), Eiman Mukhtar, Luigi Portella, Adeline Berger, Daniel Worroll, (unknown), David S. Rickman, David M. Nanus, Paraskevi Giannakakou	14
2	Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer 2021 ·Nature Communications ·Nicholas J. Brady, (unknown), Richa Singh, Vincenza Conteduca, Lucie Van Emmenis, (unknown), Hubert Pakula, (unknown), Francesca Khani, Martin Bakht, Michael Sigouros, Rohan Bareja, Andrea Sboner, Olivier Elemento, Scott T. Tagawa, David M. Nanus, Massimo Loda, Himisha Beltran, Brian D. Robinson, David S. Rickman	50
3	RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer 2021 ·Cancer Research ·Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Nicholas J. Brady, John K. Lee, Holly M. Nguyen, Dapei Li, Brian Hanratty, Michael C. Haffner, David S. Rickman, Lawrence D. True, Daniel W. Lin, Hung‐Ming Lam, Joshi J. Alumkal, Eva Corey, Peter S. Nelson, Colm Morrissey	23
4	N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer 2019 ·Journal of Clinical Investigation ·Adeline Berger, Nicholas J. Brady, Rohan Bareja, Brian Robinson, Vincenza Conteduca, Michael A. Augello, Loredana Puca, Adnan Ahmed, Étienne Dardenne, Xiaodong Lü, Inah Hwang, (unknown), Andrea Sboner, Olivier Elemento, Jihye Paik, Jindan Yu, Christopher E. Barbieri, Noah Dephoure, Himisha Beltran, David S. Rickman	116
5	Biology and evolution of poorly differentiated neuroendocrine tumors 2017 ·Nature Medicine ·David S. Rickman, Himisha Beltran, Francesca Demichelis, Mark A. Rubin	156
6	CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features 2013 ·Haematologica ·Bettina Bisig, Aurélien de Reyniès, Christophe Bonnet, Pierre Sujobert, David S. Rickman, Teresa Marafioti, Georges Delsol, Laurence Lamant, Philippe Gaulard, Laurence de Leval	52
7	Next-generation Prostate Cancer Biobanking 2012 ·Diagnostic Molecular Pathology ·Raquel Esgueva, Kyung Park, Robert Kim, Naoki Kitabayashi, Christopher E. Barbieri, Philip Dorsey, (unknown), Samprit Banerjee, Robert Leung, Ashutosh Tewari, Stéphane Terry, Maria M. Shevchuk, David S. Rickman, Mark A. Rubin	19
8	Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies 2011 ·Journal of Translational Medicine ·Harveer Dev, David S. Rickman, Prasanna Sooriakumaran, Abhishek Srivastava, Sonal Grover, Robert Leung, Robert Kim, Naoki Kitabayashi, (unknown), Kyung Park, (unknown), Mark A. Rubin, Ashutosh Tewari	22
9	Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing 2010 ·Genome Research ·Dorothee Pflueger, Stéphane Terry, Andrea Sboner, Lukas Habegger, Raquel Esgueva, (unknown), Maria A. Svensson, Naoki Kitabayashi, B.J. Moss, Theresa Y. MacDonald, Xuhong Cao, Terrence R. Barrette, Ashutosh Tewari, Mark S. Chee, Arul M. Chinnaiyan, David S. Rickman, Francesca Demichelis, Mark Gerstein, Mark A. Rubin	157
10	ERG Cooperates with Androgen Receptor in Regulating Trefoil Factor 3 in Prostate Cancer Disease Progression 2010 ·Neoplasia ·David S. Rickman, Ying‐Bei Chen, Samprit Banerjee, (unknown), Jindan Yu, (unknown), Sven Perner, Christopher J. Lafargue, Kirsten D. Mertz, Sunita R. Setlur, Kanishka Sircar, Arul M. Chinnaiyan, Tarek A. Bismar, Mark A. Rubin, Francesca Demichelis	46
11	An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients 2010 ·Molecular Cancer ·François Ducray, Aurélien de Reyniès, Olivier Chinot, Ahmed Idbaïh, Dominique Figarella‐Branger, Carole Colin, Lucie Karayan‐Tapon, Hervé Chneiweiss, Michel Wager, François M. Vallette, Yannick Marie, David S. Rickman, Emilie Thomas, Jean‐Yves Delattre, Jérôme Honnorat, Marc Sanson, François Berger	33
12	SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation–Specific Fusion Transcript in Prostate Cancer 2009 ·Cancer Research ·David S. Rickman, Dorothee Pflueger, B.J. Moss, (unknown), Chen X. Chen, Alexandre de la Taille, Rainer Kuefer, Ashutosh Tewari, Sunita R. Setlur, Francesca Demichelis, Mark A. Rubin	155
13	Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival 2009 ·Journal of Clinical Oncology ·Aurélien de Reyniès, Guillaume Assié, David S. Rickman, Frédérique Tissier, Lionel Groussin, Fernande René-Corail, B. Dousset, Xavier Bertagna, Éric Clauser, Jérôme Bertherat	278
14	N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer 2009 ·Neoplasia ·Dorothee Pflueger, David S. Rickman, Andrea Sboner, Sven Perner, Christopher J. Lafargue, Maria A. Svensson, B.J. Moss, Naoki Kitabayashi, Yihang Pan, Alexandre de la Taille, Rainer Kuefer, Ashutosh Tewari, Francesca Demichelis, Mark S. Chee, Mark Gerstein, Mark A. Rubin	98
15	EML4-ALK Fusion Lung Cancer: A Rare Acquired Event 2008 ·Neoplasia ·Sven Perner, Patrick Wagner, Francesca Demichelis, Rohit Mehra, Christopher J. Lafargue, B.J. Moss, (unknown), Alex Soltermann, Walter Weder, Thomas J. Giordano, David G. Beer, David S. Rickman, Arul M. Chinnaiyan, Holger Moch, Mark A. Rubin	196
16	Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays 2008 ·Oncogene ·David S. Rickman, R Millon, Aurélien de Reyniès, Emilie Thomas, Christine Wasylyk, D Müller, Joseph Abecassis, Bohdan Wasylyk	119
17	Stabilization of β-catenin affects mouse embryonic liver growth and hepatoblast fate 2007 ·Hepatology ·Thomas Decaens, Cécile Godard, Aurélien de Reyniès, David S. Rickman, François Tronche, Jean‐Pierre Couty, Christine Perret, Sabine Colnot	124
18	Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen 2007 ·PLoS Medicine ·Philippe Bertheau, Elisabeth Turpin, David S. Rickman, Marc Espié, Aurélien de Reyniès, Jean‐Paul Feugeas, Louis‐François Plassa, Hany Soliman, Mariana Varna, Anne de Roquancourt, Jacqueline Lehmann‐Che, Yves Beuzard, M. Marty, Jean-Louis Misset, Anne Janin, Hugues de Thé	132
19	Apc Tumor Suppressor Gene Is the “Zonation-Keeper” of Mouse Liver 2006 ·Developmental Cell ·Samira Benhamouche, Thomas Decaens, Cécile Godard, Régine Chambrey, David S. Rickman, Christophe Moinard, Mireille Vasseur-Cognet, Calvin J. Kuo, Axel Kahn, Christine Perret, Sabine Colnot	385
20	Comparison of the latest commercial short and long oligonucleotide microarray technologies 2006 ·BMC Genomics ·Aurélien de Reyniès, Daniela Géromin, Jean‐Michel Cayuela, Fabien Petel, Philippe Dessen, François Sigaux, David S. Rickman	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact